|
2025
|
G/S
|
Downloadable mobile applications, namely mobile applications for a digital platform to record, st... |
|
|
G/S
|
Downloadable mobile applications, namely mobile applications
for a digital platform to record, s... |
|
|
Invention
|
Fcrn/antigen-binding molecules and methods of use.
Provided herein are binding molecules compris... |
|
|
Invention
|
Methods of treating osteoarthritis and osteoarthritis pain with an anti complement c2 antagonisti... |
|
|
Invention
|
Fcrn antagonist molecules and methods of use thereof.
The disclosure provides populations of FcR... |
|
|
Invention
|
Subcutaneous formulations, pre-filled syringes and methods of use thereof. e.g.e.g.e.g., a subjec... |
|
|
Invention
|
Intravenous fcrn antagonist formulations and methods of use thereof. Provided herein are pharmace... |
|
|
Invention
|
Methods for treating lupus nephritis using fcrn antagonists.
Provided herein are methods of trea... |
|
|
Invention
|
Monovalent anti-iga binding molecules and methods of use. The present invention relates to monova... |
|
|
Invention
|
Methods for reducing platelet degradation using fcrn antagonists. Provided herein are methods of ... |
|
|
G/S
|
Medical billing; medical cost management; business administrative services for medical referrals;... |
|
|
Invention
|
Methods for treating primary sjogren's syndrome using fcrn antagonists. Provided herein are metho... |
|
|
G/S
|
Pharmaceuticals and medical preparations for therapeutic purposes in the field of immunology and ... |
|
|
G/S
|
Pharmaceuticals and medical preparations for therapeutic
purposes in the field of immunology and... |
|
|
Invention
|
Use of fcrn antagonists for treatment of generalized myasthenia gravis.
Provided are novel metho... |
|
|
Invention
|
Cd70 combination therapy.
The present invention provides combinations and methods using same for... |
|
|
Invention
|
Dosage regimens for treating multifocal motor neuropathy (mmn).
Provided are methods and dosage ... |
|
|
Invention
|
Treatment for acute myeloid leukemia with anti-cd70 antibodies.
Methods of treating acute myeloi... |
|
|
G/S
|
Wholesale and retail services for therapeutic pharmaceutical preparations in the field of immunol... |
|
|
Invention
|
Methods of treating multifocal motor neuropathy (mmn). Provided are methods and dosage regimens f... |
|
2024
|
Invention
|
Monovalent molecules binding to iga and methods of use. The present invention relates to monovale... |
|
|
Invention
|
Fcrn/hsa-binding molecules and methods of use. Provided herein are binding molecules comprising a... |
|
|
Invention
|
Ph-dependent hsa-binding molecules and methods of use.
Provided herein are pH-dependent HSA bind... |
|
|
Invention
|
Fcrn binding molecules and methods of use.
Provided herein are binding molecules comprising a hu... |
|
|
Invention
|
Fcrn/hsa binding molecules and methods of use. Provided herein are binding molecules comprising a... |
|
|
Invention
|
Compositions and methods for treating immune thrombocytopenia.
A method is disclosed for the tre... |
|
|
Invention
|
Methods of determining potency of a human neonatal fc receptor antagonist. Methods of determining... |
|
|
Invention
|
In utero treatment of a fetus having genetic disease/neuromuscular disease.
The present inventio... |
|
|
Invention
|
Methods for treating bullous pemphigoid using fcrn antagonists.
Provided herein are methods of t... |
|
|
Invention
|
Anti-mast cell antibodies. The present invention relates to methods of depleting mast cells. The ... |
|
|
Invention
|
Fcrn antagonists and methods of use.
Provided herein are human neonatal Fc receptor (FcRn) antag... |
|
|
Invention
|
Methods for treating myositis using fcrn antagonists.
Provided herein are methods of treating my... |
|
|
Invention
|
Anti-musk antibodies for use in treating neuromuscular disorders.
The present invention relates ... |
|
|
Invention
|
Bispecific antigen binding construct.
The present invention relates to bispecific and other mult... |
|
|
Invention
|
Methods for treating chronic inflammatory demyelinating polyneuropathy. The present invention rel... |
|
|
Invention
|
Nebulization of fab fragments.
The present invention relates to methods of treating a disease or... |
|
|
Invention
|
Galectin-10 antibodies.
The present invention relates to antibodies and antigen binding fragment... |
|
|
Invention
|
Method of preparing ph-dependent antibodies.
Methods for preparing engineered antibodies exhibit... |
|
|
Invention
|
Combined antagonists against il-5/il-5r and either il-4/il-4r or il-13/il-13r.
The present inven... |
|
|
Invention
|
Antibodies for use in agrin-deficient disorders. The present invention relates to a MuSK antibody... |
|
|
Invention
|
Methods for vaccination of a subject treated with an fcrn antagonist. The present disclosure prov... |
|
|
G/S
|
Conducting and organizing of seminars and conferences in the field of medical science; medical ed... |
|
|
G/S
|
Conducting and organizing of seminars and conferences in the
field of medical science; medical e... |
|
|
Invention
|
Subcutaneous unit dosage forms.
Provided herein are unit dosage forms of a biologic that are det... |
|
|
Invention
|
Methods for treating pots using fcrn antagonists. Provided herein are methods of treating postura... |
|
2023
|
Invention
|
Anti-il-9 antibodies and methods of use thereof.
The instant disclosure provides isolated antibo... |
|
|
Invention
|
Fcrn antagonist molecules and methods of use thereof. The disclosure provides populations of FcRn... |
|
|
Invention
|
Methods for treating lupus nephritis using fcrn antagonists. Provided herein are methods of treat... |
|
|
Invention
|
Methods for treating primary membranous nephropathy using fcrn antagonists. Provided herein are m... |
|
|
Invention
|
Il-6 binding molecules.
The present invention provides binding molecules (e.g., antibodies or an... |
|
|
G/S
|
Human pharmaceuticals for treatment of autoimmune diseases and disorders; pharmaceutical preparat... |
|
|
G/S
|
Pharmaceuticals; pharmaceutical preparations and
compositions for the treatment of autoimmune,
... |
|
|
Invention
|
Galectin-10 antibodies.
The present invention relates to antagonists, particularly antibodies an... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of autoimmune diseases and disorders |
|
|
G/S
|
Pharmaceuticals; pharmaceutical preparations and
compositions. |
|
|
Invention
|
Method of treatment of patients having reduced sensitivity to a bcl-2 inhibitor.
Provided are an... |
|
2022
|
Invention
|
Binding molecules targeting il-2 receptor.
The present invention provides binding molecules, par... |
|
2020
|
G/S
|
Pharmaceuticals for the treatment of autoimmune diseases and disorders; pharmaceutical preparatio... |
|
|
Invention
|
Antagonists of the complement system for use in methods of treating paraproteinemic neuropathies.... |
